b*****n 发帖数: 34 | 1 小弟肿瘤免疫方向的博士毕业,最近看到百济神州(beigene)的招聘启事。感觉他们
做的东西还不错,高管也都是比较有资历的海归。这几个靶点虽然不新,但是如果能有
改良或者好的联合疗法,再国内貌似会有不错的市场。
请教下不知道有没有懂行的可以点评下?
多谢 |
C*********h 发帖数: 83 | |
b*****n 发帖数: 34 | 3 很多广告啊,留园上也有的。。。
【在 C*********h 的大作中提到】![](/moin_static193/solenoid/img/up.png) : 目前只出不进,应该不招人吧
|
l**********x 发帖数: 28 | |
b*****n 发帖数: 34 | |
t*******4 发帖数: 1 | 6 Beigene is on the highway to much better future. Already, 3 drugs have been
in clinical trials. Milestone payments from Merck have achieved. You guess
why? The reasonalbe explainations are that good results were obtained.
Beigene is not just working on "me 2 drug". Beigene drugs work better. |
C*********h 发帖数: 83 | 7 这个是Beigene的那个Tony吗?
been
【在 t*******4 的大作中提到】![](/moin_static193/solenoid/img/up.png) : Beigene is on the highway to much better future. Already, 3 drugs have been : in clinical trials. Milestone payments from Merck have achieved. You guess : why? The reasonalbe explainations are that good results were obtained. : Beigene is not just working on "me 2 drug". Beigene drugs work better.
|
D******7 发帖数: 13 | |